Innovation in Cancer, Infectious Disease Research

News   Jan 20, 2017 | Original story from UC Berkeley

 
Innovation in Cancer, Infectious Disease Research

Stephen Isaacs, CEO of Aduro Biotech, at the launch of the IVRI on March 23. (Peg Skorpinski photos)

 
 
 

RELATED ARTICLES

Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein Target

News

A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.

READ MORE

Protein Essential for Making Stem Cells Identified

News

The discovery by Stanford scientists drills a peephole into the black box of cellular reprogramming and may lead to new ways to generate induced pluripotent stem cells in the laboratory.

READ MORE

Detecting Heart Damage Long Before Parkinson's Symptoms Appear

News

Mapping inflammation in the heart before diagnosis of Parkinson's disease: a new tool for tracking treatment efficacy

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy